We are live on ! Find out more
CUAMC

China Universal Asset Management Company Portfolio holdings

AUM $1.67B
1-Year Est. Return 89%
This Fund
S&P 500
This Quarter Est. Return
+18.11%
1 Year Est. Return
+89%
3 Year Est. Return
+264.17%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$514M
AUM Growth
+$169M
Cap. Flow
+$103M
Cap. Flow %
19.96%
Top 10 Hldgs %
26.88%
Holding
503
New
57
Increased
239
Reduced
90
Closed
78

Top Buys

Rank Stock Value
1
VRTX icon
Vertex Pharmaceuticals
VRTX
+$6.25M
2
GILD icon
Gilead Sciences
GILD
+$6.13M
3
REGN icon
Regeneron Pharmaceuticals
REGN
+$6.05M
4
AMGN icon
Amgen
AMGN
+$5.9M
5
ADBE icon
Adobe
ADBE
+$5.02M

Top Sells

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$4.85M
2
ADI icon
Analog Devices
ADI
+$3.37M
3
AMZN icon
Amazon
AMZN
+$3.21M
4
LULU icon
lululemon athletica
LULU
+$2.87M
5
ORCL icon
Oracle
ORCL
+$1.91M

Sector Composition

Rank Sector Weight
1 Technology 34.39%
2 Healthcare 30.05%
3 Consumer Discretionary 17.55%
4 Communication Services 6.11%
5 Consumer Staples 4.61%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RARE icon
151
Ultragenyx Pharmaceutical
RARE
$2.65B
$454K 0.09%
9,501
+7,670
+419% +$297K
AXSM icon
152
Axsome Therapeutics
AXSM
$11.2B
$436K 0.08%
5,475
+4,271
+355% +$286K
RBLX icon
153
Roblox
RBLX
$25.4B
$424K 0.08%
9,284
– –
CSCO icon
154
Cisco
CSCO
$488B
$408K 0.08%
8,084
-7,101
-47% -$363K
BAR icon
155
GraniteShares Gold Shares
BAR
$1.49B
$408K 0.08%
20,000
-5,000
-20% -$97.7K
KRYS icon
156
Krystal Biotech
KRYS
$9.85B
$404K 0.08%
3,259
+2,541
+354% +$282K
ADI icon
157
Analog Devices
ADI
$187B
$395K 0.08%
1,991
-18,866
-90% -$3.37M
XENE icon
158
Xenon Pharmaceuticals
XENE
$6.31B
$394K 0.08%
8,546
+6,895
+418% +$244K
IBRX icon
159
ImmunityBio
IBRX
$8.2B
$388K 0.08%
77,235
+65,533
+560% +$206K
ARWR icon
160
Arrowhead Research
ARWR
$12.3B
$380K 0.07%
12,429
+9,676
+351% +$257K
TMUS icon
161
T-Mobile US
TMUS
$190B
$371K 0.07%
2,314
-2,070
-47% -$306K
GH icon
162
Guardant Health
GH
$22.2B
$369K 0.07%
13,652
+9,231
+209% +$242K
FTRE icon
163
Fortrea Holdings
FTRE
$1.74B
$358K 0.07%
+10,268
New +$314K
CMCSA icon
164
Comcast
CMCSA
$90.4B
$351K 0.07%
8,007
-7,329
-48% -$314K
INTU icon
165
Intuit
INTU
$91.6B
$348K 0.07%
556
-488
-47% -$269K
DNLI icon
166
Denali Therapeutics
DNLI
$4.04B
$343K 0.07%
15,981
+12,455
+353% +$247K
AMPH icon
167
Amphastar Pharmaceuticals
AMPH
$850M
$343K 0.07%
5,542
+4,281
+339% +$225K
ALV icon
168
Autoliv
ALV
$8.85B
$331K 0.06%
3,000
– –
PACB icon
169
Pacific Biosciences
PACB
$345M
$322K 0.06%
32,855
+12,628
+62% +$103K
NTLA icon
170
Intellia Therapeutics
NTLA
$1.69B
$316K 0.06%
10,355
+8,092
+358% +$233K
RYTM icon
171
Rhythm Pharmaceuticals
RYTM
$8.1B
$314K 0.06%
6,837
+5,379
+369% +$170K
ACLX
172
DELISTED
Arcellx
ACLX
$313K 0.06%
5,632
+4,384
+351% +$198K
RCKT icon
173
Rocket Pharmaceuticals
RCKT
$374M
$312K 0.06%
10,424
+8,356
+404% +$184K
CBAY
174
DELISTED
Cymabay Therapeutics
CBAY
$310K 0.06%
13,114
+10,598
+421% +$189K
TXN icon
175
Texas Instruments
TXN
$253B
$309K 0.06%
1,811
-1,572
-46% -$244K
5 6
7
8 9

Similar funds

HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
JPM
JANA Partners Management New York $1.67B AUM 1.66% 1-Year Est. Return
CPO
Cerity Partners OCIO New York $1.67B AUM 13.22% 1-Year Est. Return
LCI
L1 Capital International Sydney NSW 2000, Australia $1.68B AUM 9.83% 1-Year Est. Return
GWM
GDS Wealth Management Flower Mound, Texas $1.66B AUM 18.11% 1-Year Est. Return
JIP
Jaffetilchin Investment Partners Tampa, Florida $1.68B AUM 22.81% 1-Year Est. Return
RMC
Ribbit Management Company Palo Alto, California $1.68B AUM 40.61% 1-Year Est. Return
GACM
Global Alpha Capital Management Montreal, Quebec, Canada $1.66B AUM 27.98% 1-Year Est. Return

China Universal Asset Management Company's Q4 2023 Portfolio in Review

As of Q4 2023, China Universal Asset Management Company held 503 positions worth $514M, up 49% from $345M the previous quarter. Its ten largest holdings account for 27% of the portfolio.

China Universal Asset Management Company deployed $103M of net new capital in Q4 2023, opening 57 new positions and adding to 239 existing holdings. Its largest new stake was GSK: 54,345 shares worth $2.03M.

By sector, the portfolio is most concentrated in Technology at 34% of assets, down from 38% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was NVIDIA, an estimated $4.85M trimmed.

  • China Universal Asset Management Company's largest Q4 2023 buy was GSK: 54,345 shares worth $2.03M.
  • China Universal Asset Management Company added most to Vertex Pharmaceuticals in Q4 2023, an estimated $6.25M increase.
  • China Universal Asset Management Company's biggest Q4 2023 reduction was NVIDIA, cutting an estimated $4.85M.
  • China Universal Asset Management Company fully exited Oracle in Q4 2023, selling an estimated $1.91M.
  • China Universal Asset Management Company's ten largest holdings make up 27% of its $514M portfolio in Q4 2023.
  • China Universal Asset Management Company opened 57 new positions and closed 78 in Q4 2023.
  • China Universal Asset Management Company's portfolio value rose 49% quarter-over-quarter to $514M.

Based on China Universal Asset Management Company's 13F filing for Q4 2023, filed 24 Jan 2024.